Role of Defensins and Cathelicidin LL37 in Auto-Immune and Auto- Inflammatory Diseases
Journal:
Current Pharmaceutical Biotechnology
Volume:
13
Page:
1882-1897
Author(s):
Loredana Frasca and Roberto Lande
The Role of Bacterial Lipopolysaccharides as Immune Modulator in Vaccine and Drug Development
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
12
Page:
221-235
Author(s):
Jesus Arenas
Nanotools for the Delivery of Antimicrobial Peptides
Journal:
Current Drug Targets
Volume:
13
Page:
1158-1172
Author(s):
Patricia Urban, Juan Jose Valle-Delgado, Ernest Moles, Joana Marques, Cinta Diez and Xavier Fernandez-Busquets
Blood-Brain Barrier Integrity and Glial Support: Mechanisms that can be Targeted for Novel Therapeutic Approaches in Stroke
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
3624-3644
Author(s):
Patrick T. Ronaldson and Thomas P. Davis
Tracking Stem Cells for Cellular Therapy in Stroke
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
3685-3693
Author(s):
Nathan C. Manley and Gary K. Steinberg
Delivery of Neurotherapeutics Across the Blood Brain Barrier in Stroke
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
3704-3720
Author(s):
Xiaoming Hu, Meijuan Zhang, Rehana K Leak, Yu Gan, Peiying Li, Yanqin Gao and Jun Chen
Moxifloxacin-induced Hypoglycemia in a Non-diabetic Patient
Journal:
Current Drug Safety
Volume:
7
Page:
183-185
Author(s):
Divyesh R. Mandavia, Mukund M. Virpariya, Tejas K. Patel and C. B. Tripathi
Bladder Cancer: A Simple Model Becomes Complex
Journal:
Current Genomics
Volume:
13
Page:
395-415
Author(s):
Giovanni Battista Di Pierro, Caterina Gulia, Cristiano Cristini, Giorgio Fraietta, Lorenzo Marini, Pietro Grande, Vincenzo Gentile and Roberto Piergentili
Targeting Matrix Metalloproteinases in Acute Inflammatory Shock Syndromes
Journal:
Combinatorial Chemistry & High Throughput Screening
Volume:
15
Page:
555-570
Author(s):
Zheng Qiu, Jialiang Hu, Philippe E. Van den Steen and Ghislain Opdenakker
Pathology of Multiple Sclerosis
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
11
Page:
506-517
Author(s):
Markus Kipp, Paul van der Valk and Sandra Amor